Ithemba Labs
iThemba LABS is South Africa's national accelerator-based science facility under the NRF, operating particle accelerators in Cape Town and Johannesburg to produce medical radioisotopes, conduct nuclear physics research, and train scientists across Africa.
- Company typePrivate
- Founded1987
- HeadquartersSomerset West, South Africa
- Headcount251–500
- GTM typeB2B
- OfferingServices
What Ithemba Labs does
iThemba Laboratories for Accelerator-Based Science (LABS) is a South African national research facility operating as a business unit of the National Research Foundation (NRF) under the Department of Science and Innovation. Headquartered in Faure, Western Cape, with a secondary Gauteng campus in Johannesburg, the facility runs Africa's largest cluster of particle accelerators, anchored by the 200-MeV Separated Sector Cyclotron (SSC) and supplemented by a 3-MV Tandetron, a 6-MV Tandem accelerator, the Accelerator Mass Spectrometry (AMS) facility, the GAMKA gamma-ray spectrometer, and the AFRODITE detector array.
The facility serves three primary user communities: nuclear medicine (production and distribution of radiopharmaceuticals to 80+ national public and private nuclear medicine departments and ~100 international clients), nuclear physics research (fundamental and applied, including nuclear reactions, nuclear structure, nuclear astrophysics, neutron metrology, and radiation damage studies), and applied materials/environmental analysis (PIXE, RBS, ERDA, XRD, AFM, and radio-carbon dating). Recent infrastructure additions — the 2023 South African Isotope Facility (SAIF), a dedicated medical cyclotron, and the Technology Innovation Platform (TIP) — have separated isotope production from research beam time and opened a commercialization channel for detector technology. Human capacity development is centralized under SAINTS, while international engagement runs through long-standing SA-CERN (since 2008) and SA-JINR (20+ years) programmes and a 2025 trilateral with INRS (Quebec).
The revenue model is hybrid but government-dominated: baseline funding flows through NRF/DSI appropriations, with incremental revenue from commercial isotope and radiopharmaceutical sales and from research services rendered to universities and industrial clients (e.g., mining sector environmental monitoring). Pricing is not publicly disclosed; services are provided through research agreements and institutional collaborations rather than standard commercial terms. The customer base spans healthcare providers, academic and research institutions, students and early-career researchers, and mining/environmental agencies — with the South African government acting as the de facto anchor funder.
Ithemba Labs firmographics
Firmographics- Name
- Ithemba Labs
- Legal name
- iThemba Laboratories for Accelerator-Based Science
- Website
- https://tlabs.ac.za
- Company type
- Private
- Founded year
- 1987
- Operating status
- Operating
- Headcount range
- 251–500 employees
- Short description
- iThemba LABS is South Africa's national accelerator-based science facility under the NRF, operating particle accelerators in Cape Town and Johannesburg to produce medical radioisotopes, conduct nuclear physics research, and train scientists across Africa.
- Ownership category
- akta.pro rank
Ithemba Labs industry classification
Industry- Product category
- Nuclear Research and Isotope Production Services
- NAICS
- Irradiation Apparatus Manufacturing (334517), Medical and Diagnostic Laboratories (62151), Analytical Laboratory Instrument Manufacturing (334516)
- SIC
- Laboratory Analytical Instruments (3826), Services-Commercial Physical & Biological Research (8731), Industrial Instruments For Measurement, Display, And Control (3823)
- akta.pro primary industry
- Radioisotope Production (Reactor/Cyclotron/Gamma) (HLAIAGAD)
- akta.pro secondary industries
- Medical Radioisotope Production (Reactor/Cyclotron, Mo-99/Tc-99m, I-131, Lu-177, etc.) (EUAKAIAA), Radiation Detection Instruments & Systems (Portal monitors, spectrometers, contamination monitors) (EUAKAIAK), Research & Test Reactor Operations (Non-Commercial Power) (EUACADAH), Nuclear Medicine Clinical Services & Therapy Centers (HLAIAGAI)
Keywords
Where Ithemba Labs is headquartered
LocationHeadquarters
- HQ city
- Somerset West
- HQ country
- South Africa
- HQ region
- Africa
Offices2 records
Markets served
Ithemba Labs business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Technology or R&D, Infrastructure, Operations, Supply Chain
Revenue model
- Government Funding (NRF): As a business unit of the National Research Foundation (NRF), iThemba LABS receives government funding for operations, infrastructure maintenance, and research programs.
- Nuclear Medicine and Isotope Sales: Production and sale of medical radioisotopes for diagnostics, imaging, and therapy. Supplies radiopharmaceuticals to over 80 national public and private nuclear medicine departments and longer half-life radionuclide products to nearly 100 international clients.
- Research Services and Training: Provides research infrastructure access, training programs, and specialized services to academic institutions, researchers, and students through partnerships with universities.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Annual | Research infrastructure access for academic and research institutions |
Go-to-market motion1 record
Distribution channels3 records
Marketing channels5 records
Ithemba Labs product offering
Product offeringCore offering
iThemba LABS operates particle accelerators including the 200-MeV Separated Sector Cyclotron (SSC) for nuclear physics research and isotope production. It produces and supplies medical radioisotopes and radiopharmaceuticals to over 80 national nuclear medicine departments and nearly 100 international clients. The facility also provides accelerator-based research infrastructure access, training programs, and specialized materials analysis services to academic, research, and industry clients.
Product overview
iThemba LABS operates as a unified research facility providing accelerator-based science services through multiple integrated components. The core offering centers on the 200-MeV Separated Sector Cyclotron (SSC) for nuclear physics and isotope production, complemented by the South African Isotope Facility (SAIF) for dedicated medical isotope production. Supporting infrastructure includes the Tandetron Laboratory for materials research and the AMS Facility for isotope analysis. Training and development is consolidated under SAINTS, while international collaboration is facilitated through SA-CERN and SA-JINR programmes. The facility also hosts GAMKA gamma-ray spectrometer and the Technology Innovation Platform (TIP) for commercialization. Together these products form a comprehensive ecosystem for accelerator-based research, isotope production, and human capacity development in nuclear sciences across Africa.
Differentiator
Problem solved
Functional benefit
Products and services
- Nuclear Medicine and Isotope Production Produces medical radioisotopes used in diagnostics, imaging, and therapy. Supplies radiopharmaceuticals to more than 80 national public and private nuclear medicine departments and longer half-life radionuclide products to nearly 100 international clients.
- Basic and Applied Nuclear Physics Research Provides laboratories for nuclear physics experiments including Nuclear Reactions, Nuclear Structure, Nuclear Astrophysics, neutron metrology, and radiation damage studies. Features the K=600 magnetic spectrometer and AFRODITE gamma-ray detector array.
- Tandetron Laboratory Features a 3-MV Tandetron accelerator dedicated to materials research with capabilities for ion beam analysis (IBA), including PIXE, RBS, ERDA, XRD, and AFM techniques. Also hosts a low-energy nuclear astrophysics beamline for proton capture reaction studies.
- Accelerator Mass Spectrometry (AMS) Facility State-of-the-art facility for isotope analysis with applications in climate change, archaeology, and cultural heritage studies. Located at the Johannesburg (Gauteng) campus.
- South African Isotope Facility (SAIF) Established in 2023, SAIF enables isotope production for medical, industrial, and research purposes, freeing up beam time on the SSC for fundamental and applied nuclear physics research.
- Southern African Institute for Nuclear Technology and Sciences (SAINTS) Training and development platform offering postgraduate student training, workshops, summer schools, and vocational programmes in accelerator-based science, nuclear sciences, materials science, radiation protection, radiochemistry, and AI/ML.
- SA-CERN Programme Provides South African research scientists, engineers, and students with access to CERN's Large Hadron Collider facilities in Geneva, Switzerland, and leverages technology transfer opportunities through participation in the ATLAS experiment.
- SA-JINR Programme
Companies that use Ithemba Labs
Customer profileNamed customers4 records
Segments4 records
Ideal customer profiles3 records
Ithemba Labs technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature8 records
Ithemba Labs partnerships and signals
Strategic signalPartnerships
Eight partnerships are on record, tiered core, minor and major.
- INRS (Institut national de la recherche scientifique)coreStrategic partnership signed between INRS, University of South Africa, and iThemba LABS to enhance scientific and academic collaboration between Quebec and South Africa. Focuses on joint research, shared infrastructure, and researcher/student mobility.
- Vaal University of Technology (VUT)minorVUT visited iThemba LABS to explore collaboration opportunities for student training and staff development within accelerator-based sciences. A Memorandum of Agreement is being considered.
- NMISA (National Metrology Institute of South Africa)majorAgreement signed nominating iThemba LABS as a designated facility for medium- and high-energy neutron measurements. Series of upgrades resulted in the neutron facility meeting requirements of a high-energy neutron metrology facility in 2020.
- UNESCO and UNISAcoreUNESCO-UNISA Africa Chair in Nanoscience and Nanotechnology established through trilateral collaboration. Oversees training and mentoring of early-career scientists and postgraduates in nanoscience, nanotechnology, and innovation.
- NTP (Pty) LtdcoreCollaboration with NTP (Pty) Ltd, a subsidiary of NECSA, for the inauguration of an 11-MeV cyclotron dedicated to production of 18F (fluorodeoxyglucose) for nuclear medicine, enabling delivery to the South African nuclear medicine community.
- CERN (European Centre for Nuclear Research)coreiThemba LABS is the institutional host of the SA-CERN Programme, linking South Africa to CERN's Large Hadron Collider. The programme provides access to CERN facilities for South African scientists, engineers, and students, and contributes to the ATLAS experiment. Collaborating universities include UCT, Wits, UKZN, and Johannesburg.
- JINR (Joint Institute for Nuclear Research)core20-year partnership through the SA-JINR programme. Includes student exchange, summer schools, joint research projects, and the recently established JINR Information Centre at iThemba LABS. More than 20 projects covering research thematic areas at JINR.
- National University of Singapore (CIBA)minorDr Yanxin Dou from NUS visited to work with iThemba LABS scientists on reducing the nuclear microprobe spot size to less than 1µm², a first for Africa.
Scale indicators5 records
Recent moves10 records
Expansion highlights6 records
Ithemba Labs competitors and assessment
Company assessmentBroad incumbents
- Joint Institute for Nuclear Research (JINR): International nuclear physics laboratory in Dubna, Russia, with whom iThemba LABS has maintained a 20-year strategic partnership. Operates a comparable mix of fundamental nuclear physics, detector development, and training programmes that mirror iThemba LABS' SAINTS and GAMKA activities.
- Curium Pharma: Global commercial radiopharmaceutical manufacturer and distributor. Curium competes in the same international longer half-life radionuclide market where iThemba LABS supplies ~100 international customers, making it a commercial comparable in the isotope revenue stream.
- Nuclear Energy Corporation of South Africa (NECSA): State-owned nuclear entity that houses the Safari-1 research reactor and the NTP radioisotope subsidiary. NECSA is the South African national nuclear authority under which iThemba LABS' isotope supply ecosystem operates, making it a structural peer and parent of the most direct local competitor.
Direct peers
- TRIUMF: Canada's particle accelerator centre operates a comparable model of government-funded fundamental nuclear physics research combined with commercial-scale medical isotope production. Overlaps directly with iThemba LABS on cyclotron-based isotope supply and proton/particle therapy history.
- LNL INFN (Legnaro National Laboratories): Italian national accelerator laboratory operating tandem accelerators and superconducting LINAC for nuclear structure and applied research. The use of Tandem/Tandetron accelerators and ion beam analysis capabilities maps directly onto iThemba LABS' Western Cape and Gauteng facilities.
- Australian Nuclear Science and Technology Organisation (ANSTO): ANSTO operates the OPAL research reactor and produces medical radioisotopes for domestic and export markets, combining fundamental nuclear research with a commercial radiopharmaceutical business — the same dual model that defines iThemba LABS.
- NTP Radioisotopes (Pty) Ltd: South African subsidiary of NECSA and direct in-country peer and partner of iThemba LABS in radioisotope production. NTP co-inaugurated the 11-MeV cyclotron for 18F production at iThemba LABS and is the primary local competitor in radiopharmaceutical supply.
- Paul Scherrer Institute (PSI): Swiss national lab operating high-power cyclotrons for fundamental nuclear physics and large-scale medical isotope production. Closely comparable in scope, funding model, and product mix to iThemba LABS' SSC and dedicated cyclotron operations.
- GANIL (Grand Accélérateur National d'Ions Lourds): French national heavy-ion accelerator facility with a research portfolio covering nuclear structure, nuclear reactions, and nuclear astrophysics — directly mirroring iThemba LABS' SSC-based BASIC SCIENCE programme and use of detector arrays like AFRODITE and GAMKA.
Regional players
- Variable Energy Cyclotron Centre (VECC): Indian national accelerator facility operating cyclotrons for nuclear physics research and medical radioisotope production. Comparable in scale and mandate to iThemba LABS as a government-funded emerging-market accelerator laboratory.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Ithemba Labs social profiles
Digital presenceIthemba Labs compliance and trust
Trust signalCompliance1 record
Ithemba Labs financial estimates
Financial estimateRevenue estimate
Valuation estimate
Ithemba Labs leadership team
Management profileNumber of profiles
Profiles16 records
Ithemba Labs funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Ithemba Labs M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Ithemba Labs
What does Ithemba Labs do?
iThemba LABS operates particle accelerators including the 200-MeV Separated Sector Cyclotron (SSC) for nuclear physics research and isotope production. It produces and supplies medical radioisotopes and radiopharmaceuticals to over 80 national nuclear medicine departments and nearly 100 international clients. The facility also provides accelerator-based research infrastructure access, training programs, and specialized materials analysis services to academic, research, and industry clients.
Is Ithemba Labs a public or private company?
Ithemba Labs is a private company. It is classified as state government owned and is currently operating.
When was Ithemba Labs founded?
Ithemba Labs was founded in 1987. It employs 251 to 500 people.
Where is Ithemba Labs based?
Ithemba Labs is headquartered in Somerset West, South Africa, in the Africa region.
How does Ithemba Labs make money?
Three revenue lines are on record. Government Funding (NRF) is the primary driver. The others are nuclear Medicine and Isotope Sales and research Services and Training.
Who are Ithemba Labs's main competitors?
Broad incumbents on record are Joint Institute for Nuclear Research (JINR), Curium Pharma and Nuclear Energy Corporation of South Africa (NECSA). Direct peers are TRIUMF, LNL INFN (Legnaro National Laboratories), Australian Nuclear Science and Technology Organisation (ANSTO), NTP Radioisotopes (Pty) Ltd, Paul Scherrer Institute (PSI) and GANIL (Grand Accélérateur National d'Ions Lourds). Variable Energy Cyclotron Centre (VECC) is listed as a regional player.
Does Ithemba Labs have an API?
No public API is recorded for Ithemba Labs.
What industry is Ithemba Labs in?
Ithemba Labs's product category is Nuclear Research and Isotope Production Services. Its primary akta.pro industry code is HLAIAGAD, Radioisotope Production (Reactor/Cyclotron/Gamma), with a secondary code of EUAKAIAA, Medical Radioisotope Production (Reactor/Cyclotron, Mo-99/Tc-99m, I-131, Lu-177, etc.). Its NAICS code is 334517 and its SIC code is 3826.